Analysis Version
v1
History
Back to Study: Glucagon-like peptide-1 receptor agonists as a dis...
quantitative
Analysis v1
Strong Support

For adults with knee pain from arthritis and type 2 diabetes, taking GLP-1 drugs like Ozempic may slightly reduce pain based on a scoring system, but the change is probably too small for people to actually notice in their daily lives.

67
Pro
0
Against

Evidence from Studies

Supporting (1)

67

Community contributions welcome

67

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Cohort Study
Human
2023 Sep

The study looked at people with knee arthritis and diabetes who took GLP-1 drugs and found their pain scores improved by a small, measurable amount—but probably not enough to actually feel better in daily life.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort

Score: 67
DOI: 10.1136/ard-2023-223845

Similar Assertions

Some diabetes drugs called GLP-1 agonists might help ease knee pain in adults with osteoarthritis, but there’s only early hints from a couple of small studies — not enough proof yet to say for sure.

48
0
86%

People with knee arthritis and diabetes who take GLP-1 drugs like Ozempic seem to need knee surgery less often — 1.7% of them did over 6 years, compared to 5.9% who didn’t take the drugs — and some of this benefit comes from losing weight.

0
8
85%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs (like Ozempic) may be less likely to need knee surgery—only 1.7% did, compared to 5.9% who didn’t take the drugs, over about 8 years.

67
0
83%

People with knee arthritis and type 2 diabetes who take GLP-1 drugs like Ozempic might lose knee cartilage more slowly, which could help delay joint damage.

67
0
83%

Some diabetes drugs might help people with knee or joint pain from osteoarthritis feel better and move easier, especially if they also have type 2 diabetes or are overweight.

1
0
83%